West Pharmaceutical Services

WST · NYSE

$388.78+$4.87 (+1.27%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $383.91

Latest news

Press releaseOct 19, 6:04 PM ETPRNewswire
West Declares Quarterly Dividend
NewsOct 19, 3:10 PM ETPiero Cingari
This 146-Old Can Maker Is On a Winning Streak Unseen In Its Half-Century Stock History
NewsOct 14, 8:09 AM ETAvi Kapoor
Meta, JPMorgan, West Pharmaceutical And More: CNBC’s ‘Final Trades’
Press releaseOct 8, 6:00 AM ETPRNewswire
West to Host Third-Quarter 2026 Conference Call
Press releaseOct 5, 6:00 AM ETPRNewswire
West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide
Press releaseAug 26, 4:00 PM ETPRNewswire
West to Participate in Upcoming Investor Conferences
NewsJul 23, 11:32 AM ETVandana Singh
West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum
NewsJul 23, 9:22 AM ET
Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings Call
NewsJul 23, 7:11 AM ET
Earnings Scheduled For July 23, 2026
NewsJul 23, 6:07 AM ET
West Pharmaceutical Servs Q2 Adj. EPS $2.37 Beats $2.08 Estimate, Sales $872.300M Beat $838.586M Estimate
Press releaseJul 21, 4:00 PM ETPRNewswire
West Declares Quarterly Dividend
Press releaseJul 7, 6:00 AM ETPRNewswire
West to Host Second-Quarter 2026 Conference Call
Press releaseJul 1, 4:30 PM ETPRNewswire
West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System
Press releaseJun 1, 4:30 PM ETPRNewswire
West Appoints Michel Lagarde to be President and Chief Executive Officer
NewsMay 19, 1:37 PM ETVandana Singh
Trump's Stock Picks Perfectly Timed With New Medicare Rules: Report
NewsMay 12, 1:59 PM ETVandana Singh
Investors Await Damage Assessment After West Pharmaceutical Cyberattack
Press releaseApr 28, 6:00 AM ETPRNewswire
West to Participate in Upcoming Investor Conferences
NewsApr 23, 1:42 PM ETVandana Singh
West Pharmaceutical Lifts Annual Guidance After Strong GLP-1 Driven Growth In Q1
NewsApr 23, 12:52 PM ETPiero Cingari
Nasdaq 100 Eases From Records As Software Stocks Plunge: Stock Market Today
NewsApr 23, 9:18 AM ET
West Pharmaceutical Servs Reports Q1 2026 Results: Full Earnings Call Transcript
NewsApr 23, 8:07 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsApr 23, 7:23 AM ET
Market-Moving News for April 23rd
Press releaseApr 23, 6:00 AM ETPRNewswire
West Reports First-Quarter 2026 Results
Press releaseApr 9, 6:00 AM ETPRNewswire
West to Host First-Quarter 2026 Conference Call
Press releaseMar 31, 11:46 AM ETPRNewswire
West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity
NewsMar 10, 1:03 PM ETPiero Cingari
Oil Crashes 10%, Stocks Rebound On Trump End-Of-War Signals: What's Moving Markets Tuesday?
Press releaseMar 9, 4:30 PM ETPRNewswire
Eric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc.
Press releaseFeb 27, 6:00 AM ETPRNewswire
West to Participate in Upcoming Investor Conferences
NewsFeb 17, 4:02 PM ET
West Pharmaceutical Services' Board Authorizes New $1B Share Repurchase Program
Press releaseFeb 17, 4:00 PM ETPRNewswire
West Announces Quarterly Dividend and Share Repurchase Program
Press releaseFeb 12, 6:00 AM ETPRNewswire
West Reports Fourth-Quarter and Full-Year 2025 Results
Press releaseJan 29, 6:00 AM ETPRNewswire
West to Host Fourth-Quarter and Full-Year 2025 Conference Call
Press releaseJan 21, 9:55 AM ETGlobe Newswire
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
Press releaseJan 20, 6:00 AM ETPRNewswire
West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack
Press releaseJan 12, 6:00 AM ETPRNewswire
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie
NewsOct 27, 6:10 AM ET
1. West Pharmaceutical Unveils New Prefillable Syringe System for Biologics and Vaccines, Launches Synchrony Syringe Platform, Set for 2026 Release
Press releaseOct 27, 6:00 AM ETPRNewswire
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
Press releaseMay 30, 10:08 AM ETGlobe Newswire
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Treace Medical Concepts, Inc. (NASDAQ: TMCI); Virtu Financial Inc. (NASDAQ: VIRT); and West Pharmaceutical Services, Inc. (NYSE: WST)

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

West Declares Quarterly Dividend

This 146-Old Can Maker Is On a Winning Streak Unseen In Its Half-Century Stock History

Meta, JPMorgan, West Pharmaceutical And More: CNBC’s ‘Final Trades’

West to Host Third-Quarter 2026 Conference Call

West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide

West to Participate in Upcoming Investor Conferences

West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum

Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings Call

Earnings Scheduled For July 23, 2026

West Pharmaceutical Servs Q2 Adj. EPS $2.37 Beats $2.08 Estimate, Sales $872.300M Beat $838.586M Estimate

West Declares Quarterly Dividend

West to Host Second-Quarter 2026 Conference Call

West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System

West Appoints Michel Lagarde to be President and Chief Executive Officer

Trump's Stock Picks Perfectly Timed With New Medicare Rules: Report

Investors Await Damage Assessment After West Pharmaceutical Cyberattack

West to Participate in Upcoming Investor Conferences

West Pharmaceutical Lifts Annual Guidance After Strong GLP-1 Driven Growth In Q1

Nasdaq 100 Eases From Records As Software Stocks Plunge: Stock Market Today

West Pharmaceutical Servs Reports Q1 2026 Results: Full Earnings Call Transcript

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Market-Moving News for April 23rd

West Reports First-Quarter 2026 Results

West to Host First-Quarter 2026 Conference Call

West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity

Oil Crashes 10%, Stocks Rebound On Trump End-Of-War Signals: What's Moving Markets Tuesday?

Eric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc.

West to Participate in Upcoming Investor Conferences

West Pharmaceutical Services' Board Authorizes New $1B Share Repurchase Program

West Announces Quarterly Dividend and Share Repurchase Program

West Reports Fourth-Quarter and Full-Year 2025 Results

West to Host Fourth-Quarter and Full-Year 2025 Conference Call

THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point

West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack

West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie

1. West Pharmaceutical Unveils New Prefillable Syringe System for Biologics and Vaccines, Launches Synchrony Syringe Platform, Set for 2026 Release

West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Treace Medical Concepts, Inc. (NASDAQ: TMCI); Virtu Financial Inc. (NASDAQ: VIRT); and West Pharmaceutical Services, Inc. (NYSE: WST)